Hybridon HYBN, for discussion of antisense drugs. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Hybridon HYBN, for discussion of antisense drugs.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JMarcus who wrote (29)	2/18/1998 8:39:00 PM
From: Mounir Abouzakhm	Read Replies (1) of 42

Marcus, In the Prohost's last issue they mentioned that they expect good news from Hybridon within 30-45 days. I was surprised to read that they plan to enroll up to 25 persons for the new Phase I. If I am not mistaken, LJPC enrolled 4 people for their Phase I. I am not worried about the trading volume that much, I do not expect a company like Hybridon to trade 100,000 shares a day anyway. What worries me is the actions of the Board of Directors. These actions caused the share holders millions of dollars and delayed new trials for God knows how long. I understand that the Biotech is a risky business, but I am a firm believer that there is a big difference between risk and stupidity. I do hope that the people who re-financed Hybridon lately did that because they believed in the future of the technology and hope to God that they advised the senior management to wake up and smell the coffee. Good luck to all of us. Mounir

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next